共 31 条
[1]
Grabowski H(2002)Returns on research and development for the 1990s new drug introductions Pharmacoeconomics 20 11-29
[2]
Vernon J(2003)The price of innovation: new estimates of drug development costs J Health Econ 22 292-306
[3]
DiMasi JA(1998)Can patents deter innovation? The anticommons in biomedical research Science 280 698-701
[4]
DiMasi JA(2002)The gene patent dilemma: balancing commercial incentives with health needs Hous J Health L Policy 2 65-106
[5]
Hansen R(2003)Engaging facts and policy: a multi-institutional approach to patent system reform Columbia Law Rev 103 1035-1135
[6]
Grabowski H(2006)The intervention principle Rev Int Econ 14 226-247
[7]
Heller MA(1984)Cost reduction, competition, and industry performance Econometrica 52 101-121
[8]
Eisenberg RS(1970)Optimal departures from marginal cost pricing Am Econ Rev 60 265-283
[9]
Andrews LB(1927)A contribution to the theory of taxation Econ J 37 47-61
[10]
Rai AK(1986)A new look at the patent system Am Econ Rev 76 199-202